Novel PET tracer targets folic acid receptor on tumor cells

07/7/2013 | News-Medical.Net

Researchers from ETH Zurich, the Paul Scherrer Institute and Merck Millipore have developed a new PET tracer that binds to folic acid receptors, which builds up on the surface of many malignant cells. The agent could be used to collect data on the size and location of a tumor as well as the efficacy of chemotherapy, in particular a possible new class of drugs targeting the receptors. The scientists have assessed the tracer in mice with cervical tumors and are preparing to conduct a clinical trial on patients with ovarian, lung and intestinal cancers.

View Full Article in:

News-Medical.Net

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Sr. Medical Device Reimbursement Specialist - Regional
Alcon
Fort Worth , TX
Assistant General Counsel/Senior Corporate Counsel - Healthcare Law Group
Genentech
94080, CA
Clinical Trials Agreements Specialist (209955)
The Henry M. Jackson Foundation for the Advancement of Military Medicine Inc.
Rockville, MD
SAFETY, HEALTH, and ENVIRONMENTAL (SHE) REGIONAL SPECIALIST
Matheson Tri-Gas, Inc.
Newark, CA
MANAGER MEDICAL GAS COMPLIANCE AND SAFETY
Matheson Tri-Gas, Inc.
Houston, TX